Abstract
Recent debate has focused on the significance of platelets generated in lung tissue. Here, we retrospectively analyzed platelet count changes in neonates requiring inhaled nitric oxide (iNO) pulmonary vasodilation therapy for pulmonary hypertension. There were no clinically significant changes in platelet count upon iNO initiation or during iNO therapy. Unexpectedly, platelet counts increased after iNO cessation. These findings argue against a clinically meaningful untapped pulmonary repository of megakaryocytes and platelets in this context, although acute platelet count increases might be expected after discontinuing iNO in some patients. Further work is needed to clarify the underlying etiology for these observations, and to better delineate the mechanisms for platelet count increases after recovery from lung injury.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by a grant from the National Institutes of Health, USA (T32HD043021 to CST), an American Academy of Pediatrics Marshall Klaus Neonatal-Perinatal Research Award (CST), a Children’s Hospital of Philadelphia Foerderer Award (CST), and the Children’s Hospital of Philadelphia Division of Neonatology.
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Not Applicable
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Not Applicable
Data Availability
All data will be made available by the authors upon request.
